AGBL5 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | 1.98652205796179E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
8.97870000571288E-10 |
Normal-vs-Stage2 |
5.60659999999658E-05 |
Normal-vs-Stage3 |
2.21960005930555E-10 |
Normal-vs-Stage4 |
1.64599999996629E-06 |
Stage1-vs-Stage2 |
2.900800E-01 |
Stage1-vs-Stage3 |
8.793600E-02 |
Stage1-vs-Stage4 |
4.567600E-01 |
Stage2-vs-Stage3 |
9.875000E-01 |
Stage2-vs-Stage4 |
6.389200E-01 |
Stage3-vs-Stage4 |
5.449600E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
1.28741461935533E-12 |
Normal-vs-AfricanAmerican |
1.49479999489444E-08 |
Normal-vs-Asian |
6.295200E-01 |
Caucasian-vs-AfricanAmerican |
1.540000E-01 |
Caucasian-vs-Asian |
1.479610E-01 |
AfricanAmerican-vs-Asian |
3.460200E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
1.90292226420752E-13 |
Normal-vs-Female |
2.3263999948675E-08 |
Male-vs-Female |
1.345240E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
1.018170E-04 |
Normal-vs-Age(41-60Yrs) |
6.55249965397786E-10 |
Normal-vs-Age(61-80Yrs) |
7.22449877699205E-11 |
Normal-vs-Age(81-100Yrs) |
1.183230E-04 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
1.858620E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
1.883570E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
8.490000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
8.496600E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.980400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.069800E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
3.255500E-03 |
Normal-vs-Grade 2 |
7.37310212883813E-11 |
Normal-vs-Grade 3 |
4.46409997856279E-09 |
Normal-vs-Grade 4 |
2.99489999466829E-08 |
Grade 1-vs-Grade 2 |
6.829800E-01 |
Grade 1-vs-Grade 3 |
6.474200E-01 |
Grade 1-vs-Grade 4 |
3.528600E-01 |
Grade 2-vs-Grade 3 |
8.707600E-01 |
Grade 2-vs-Grade 4 |
2.014800E-01 |
Grade 3-vs-Grade 4 |
2.157400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.99570000525284E-08 |
Normal-vs-ccB subtype |
6.75759448398594E-11 |
ccA subtype-vs-ccB subtype |
5.049500E-02 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
1.92780003072102E-09 |
Normal-vs-N1 |
5.439400E-01 |
N0-vs-N1 |
1.708410E-01 |
|
|